About
Feedback
MM
Melissa McCracken
Principal at Nextech Invest
MM
Melissa McCracken
Principal at Nextech Invest
Zurich, Switzerland
Connect
Overview
Investments
Tyra Biosciences
Series B
Total Funding: $310M
K36 Therapeutics
Series B
Total Funding: $100M
Alpha9 Theranostics
Series B
Total Funding: $75M
AmbAgon Therapeutics
Series A
Total Funding: $85M
Relevant Websites